TrialJournal of psychopharmacology (Oxford, England)2024

Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study.

Paul Glue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.